ASF1B promotes erythropoiesis by regulating the establishment and enrichment of H3.3 nucleosomes
Nucleic Acids Research · 05.05.2026 · 54 (9)
DOI: 10.1093/nar/gkag447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 08.05.2026. Verfasst von Jinlei Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu…. Hauptthemen laut MEDLINE: Nucleosomes, Histones, Erythropoiesis, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, NIDDK NIH HHS.
Abstract (Originalsprache)
Histone chaperone ASF1B is largely known to be functionally correlated with cell proliferation and cell cycle. We found that the expression of ASF1B was abundant together with histone variant H3.3 during in mouse fetal liver cells. However, the mechanism underlying this coordination is still unclear. HIRA, a H3.3 specific chaperone, was dispensable in fetal hematopoiesis. In contrast, we found that ASF1B predominantly regulated H3.3 encoding genes and erythroid genes, whereas ASF1A served a compensatory function. Notably, ASF1B occupied >70% of H3.3 nucleosomes and determined H3.3 enrichment at erythroid gene promoters and enhancers. However, loss of ASF1B de-repressed the expression of embryonic/fetal globin genes by altering enrichment of H3.3 and erythroid transcription factors as well as chromatin accessibility. The regulatory pathway of ASF1B in H3.3 enrichment involved the recruitment of chromatin remodeler BRG1 and accumulation of H3K27ac in active chromatin. In summary, ASF1B plays a crucial role in enrichment of H3.3 nucleosomes and establishment of the chromatin environment to affect erythroid gene expression, highlighting the therapeutic potential of ASF1B in targeting erythrocyte disorders, such as β-globin hemoglobinopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
- Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, United States.
- Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Lecong Zhou, Ann Dean, Xiang Guo
Förderung
- National Natural Science Foundation of China
- Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
- NIDDK NIH HHS
- Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital
- NIDDK
Zitieren
APA
Liu, J., Song, X., Zhou, L., Zhao, Y., Kim, J., Li, J., Dean, A., & Guo, X. (2026). ASF1B promotes erythropoiesis by regulating the establishment and enrichment of H3.3 nucleosomes. Nucleic Acids Research, 54(9). https://doi.org/10.1093/nar/gkag447
Vancouver
Liu J, Song X, Zhou L, Zhao Y, Kim J, Li J, et al. ASF1B promotes erythropoiesis by regulating the establishment and enrichment of H3.3 nucleosomes. Nucleic Acids Research. 2026;54(9). doi:10.1093/nar/gkag447
BibTeX
@article{Liu2026,
author = {Liu, Jinlei and Song, Xuemei and Zhou, Lecong and Zhao, Yangu and Kim, Juhyun and Li, Jun and Dean, Ann and Guo, Xiang},
title = {ASF1B promotes erythropoiesis by regulating the establishment and enrichment of H3.3 nucleosomes},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {9},
doi = {10.1093/nar/gkag447}
}
EUVIMED